Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Cash flows from operating activities
Net income (loss)	$ 982,997	$ (669,996)
Adjustments to reconcile net income (loss) to net cash used by operating activities
Depreciation and amortization	203,551	287,250
Accretion of obligation for lease disposal costs	24,801	19,136
Accretion of beneficial conversion feature and discount	146,311	199,757
Equity based compensation	237,474	49,093
Gain on sale of property, plant and equipment	(1,797,978)
Right-of-use asset amortization	(291)	14,532
Changes in operating assets and liabilities:
Accounts receivable	(448,147)	(272,422)
Inventories	(18,870)	169,006
Prepaids and other current assets	384,774	1,098,651
Accounts payable and accrued liabilities	(807,805)	(964,392)
Unearned revenues	142,131	(169,388)
Net cash used in operating activities	(951,052)	(238,773)
Cash flows from investing activities:
Proceeds from sale of property, plant and equipment	4,000,000
Purchase of property, plant and equipment	(55,200)	(191,666)
Net cash provided by (used in) investing activities	3,944,800	(191,666)
Cash flows from financing activities:
Proceeds from sale of stock and exercise of options and warrants	70,973	8,995
Payments on financing lease	(4,172)	(3,803)
Proceeds from the issuance of notes payable		351,250
Principal payments on notes payable	(509,257)	(329,464)
Net cash used in financing activities	(442,456)	26,978
Net increase (decrease) in cash, cash equivalents, and restricted cash	2,551,292	(403,461)
Cash, cash equivalents, and restricted cash at beginning of period	1,305,603	1,751,692
Cash, cash equivalents, and restricted cash at end of period	3,856,895	1,348,231
Supplemental disclosure of cash flow activities:
Cash paid for interest	46,894	61,320
Supplemental disclosure of noncash financing and investing transactions
Decrease in accrued interest and increase in equity for conversion  of dividends to stock	204,480	207,480
Increase in operating lease right-of-use asset and right-of-use liability  for new lease		1,603
Increase in equity and decrease in liability for the conversion of preferred stock	675,000	200,000
Non-cash increase of capitalized ARO for increased funding plan		260,715
Cash and cash equivalents	3,025,513	517,506
Restricted cash included in long-term assets	831,382	830,725
Total cash, cash equivalents, and restricted cash shown in statement of cash flows	$ 3,856,895	$ 1,348,231